Form N-PX GILEAD SCIENCES, INC. For: Jun 30
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Gilead's Bixlenvo HIV tablet for adults on complex regimens
- HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
- Sigenergy Ranks #1 Globally in S&P Global Energy H1 2026 Residential Energy Storage Market Tracker
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
